Karyopharm Expands Global Presence With European Subsidiary
October 27, 2014 08:00 ET
|
Karyopharm Therapeutics
NEWTON, Mass., Oct. 27, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, announced today that it has expanded its operational footprint...
Karyopharm Announces Clinical Data for Selinexor (KPT-330) in Advanced Solid Tumors
September 29, 2014 08:00 ET
|
Karyopharm Therapeutics
- Selinexor Demonstrates Clinical Activity in Prostate Cancer and other Solid Tumors -
- Data from Ongoing Phase 1 Clinical Study Presented at ESMO 2014 -
- Webcast Scheduled for Monday,...
Karyopharm to Host Conference Call to Discuss Selinexor (KPT-330) Data Presented at ESMO 2014
September 25, 2014 17:16 ET
|
Karyopharm Therapeutics
- Phase 1 Clinical Data in Prostate Cancer and Other Solid Tumors -
- Conference Call and Interactive Webcast Scheduled for Monday, September 29, 2014 at 4:30pm ET -
NEWTON, Mass., Sept. 25,...
Karyopharm Announces Three Clinical Data Presentations at ESMO 2014
September 09, 2014 06:30 ET
|
Karyopharm Therapeutics
NEWTON, Mass., Sept. 9, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that clinical and preclinical data for its lead...
Karyopharm Appoints Justin Renz Executive Vice President and Chief Financial Officer
August 08, 2014 07:30 ET
|
Karyopharm Therapeutics
NEWTON, Mass., Aug. 8, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class...
Karyopharm to Present at the Wedbush 2014 Life Sciences Management Access Conference
August 07, 2014 16:17 ET
|
Karyopharm Therapeutics
NEWTON, Mass., Aug. 7, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class...
Karyopharm Therapeutics Reports Second Quarter Financial Results for 2014
August 07, 2014 07:00 ET
|
Karyopharm Therapeutics
NEWTON, Mass., Aug. 7, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class...
Karyopharm to Host Second Quarter 2014 Earnings Call on August 7, 2014
August 01, 2014 16:05 ET
|
Karyopharm Therapeutics
NEWTON, Mass., Aug. 1, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company focused on nuclear transport targets, today announced that it will...
Karyopharm Announces Full Exercise of Underwriters Option to Purchase Additional Shares in Public Offering of Common Stock
June 30, 2014 08:00 ET
|
Karyopharm Therapeutics
NATICK, Mass., June 30, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI) today announced that the underwriters of its previously announced public offering of common stock have...
Karyopharm Therapeutics Announces Pricing of Public Offering of Common Stock
June 26, 2014 22:00 ET
|
Karyopharm Therapeutics
NATICK, Mass., June 26, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI) today announced the pricing of its underwritten public offering of 2,647,247 shares of its common stock at a...